124 related articles for article (PubMed ID: 32307441)
1. Detection of subclonal SETBP1 and JAK3 mutations in juvenile myelomonocytic leukemia using droplet digital PCR.
Wakamatsu M; Okuno Y; Murakami N; Miwata S; Kitazawa H; Narita K; Kataoka S; Ichikawa D; Hamada M; Taniguchi R; Suzuki K; Kawashima N; Nishikawa E; Narita A; Nishio N; Kojima S; Muramatsu H; Takahashi Y
Leukemia; 2021 Jan; 35(1):259-263. PubMed ID: 32307441
[No Abstract] [Full Text] [Related]
2. Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group.
Bresolin S; De Filippi P; Vendemini F; D'Alia M; Zecca M; Meyer LH; Danesino C; Locatelli F; Masetti R; Basso G; Te Kronnie G
Oncotarget; 2016 May; 7(20):28914-9. PubMed ID: 26980750
[TBL] [Abstract][Full Text] [Related]
3. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.
Sakaguchi H; Okuno Y; Muramatsu H; Yoshida K; Shiraishi Y; Takahashi M; Kon A; Sanada M; Chiba K; Tanaka H; Makishima H; Wang X; Xu Y; Doisaki S; Hama A; Nakanishi K; Takahashi Y; Yoshida N; Maciejewski JP; Miyano S; Ogawa S; Kojima S
Nat Genet; 2013 Aug; 45(8):937-41. PubMed ID: 23832011
[TBL] [Abstract][Full Text] [Related]
4. Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.
Stieglitz E; Troup CB; Gelston LC; Haliburton J; Chow ED; Yu KB; Akutagawa J; Taylor-Weiner AN; Liu YL; Wang YD; Beckman K; Emanuel PD; Braun BS; Abate A; Gerbing RB; Alonzo TA; Loh ML
Blood; 2015 Jan; 125(3):516-24. PubMed ID: 25395418
[TBL] [Abstract][Full Text] [Related]
5. A new player SETs in myeloid malignancy.
Trimarchi T; Ntziachristos P; Aifantis I
Nat Genet; 2013 Aug; 45(8):846-7. PubMed ID: 23892662
[TBL] [Abstract][Full Text] [Related]
6. SETBP1 mutations in juvenile myelomonocytic leukaemia and myelodysplastic syndrome but not in paediatric acute myeloid leukaemia.
Shiba N; Ohki K; Park MJ; Sotomatsu M; Kudo K; Ito E; Sako M; Arakawa H; Hayashi Y
Br J Haematol; 2014 Jan; 164(1):156-9. PubMed ID: 24117422
[No Abstract] [Full Text] [Related]
7. Mutation analysis of SIPA1 in patients with juvenile myelomonocytic leukemia.
Yoshida N; Yagasaki H; Takahashi Y; Kudo K; Manabe A; Kojima S
Br J Haematol; 2008 Sep; 142(5):850-1. PubMed ID: 18492118
[No Abstract] [Full Text] [Related]
8. Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.
Carratt SA; Braun TP; Coblentz C; Schonrock Z; Callahan R; Curtiss BM; Maloney L; Foley AC; Maxson JE
Leukemia; 2021 Dec; 35(12):3594-3599. PubMed ID: 34002029
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
Ouyang Y; Qiao C; Chen Y; Zhang SJ
Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
[TBL] [Abstract][Full Text] [Related]
10. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
Cui Y; Li B; Gale RP; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
J Hematol Oncol; 2014 Oct; 7():77. PubMed ID: 25316523
[TBL] [Abstract][Full Text] [Related]
11. Aggressive congenital juvenile myelomonocytic leukemia associated with somatic KRAS p.G13D mutation and concurrent germline IGF1R duplication.
Kothari A; Hulbert ML; Cottrell CE; Nguyen TT
Leuk Lymphoma; 2015 Apr; 56(4):1175-8. PubMed ID: 25110823
[No Abstract] [Full Text] [Related]
12. SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML.
Laborde RR; Patnaik MM; Lasho TL; Finke CM; Hanson CA; Knudson RA; Ketterling RP; Pardanani A; Tefferi A
Leukemia; 2013 Oct; 27(10):2100-2. PubMed ID: 23558523
[No Abstract] [Full Text] [Related]
13. Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples.
Behnert A; Meyer J; Parsa JY; Hechmer A; Loh ML; Olshen A; de Smith AJ; Stieglitz E
Leukemia; 2022 Jan; 36(1):279-282. PubMed ID: 34183765
[No Abstract] [Full Text] [Related]
14. Spontaneous remission of juvenile myelomonocytic leukemia with NRAS mutation.
Alsultan A; Khalifah M; Alrabiaah AA
Pediatr Hematol Oncol; 2012 Oct; 29(7):624-6. PubMed ID: 22857389
[No Abstract] [Full Text] [Related]
15. Mutation analysis of AML1 gene in pediatric primary myelodysplastic syndrome and juvenile myelomonocytic leukemia.
Masunaga A; Mitsuya T; Kadofuku T; Iwamoto S; Miyazaki A; Manabe A; Zaike Y; Tsuchida M; Nakahata T
Leuk Res; 2008 Jun; 32(6):995-7. PubMed ID: 17935781
[No Abstract] [Full Text] [Related]
16. Novel splicing-factor mutations in juvenile myelomonocytic leukemia.
Takita J; Yoshida K; Sanada M; Nishimura R; Okubo J; Motomura A; Hiwatari M; Oki K; Igarashi T; Hayashi Y; Ogawa S
Leukemia; 2012 Aug; 26(8):1879-81. PubMed ID: 22343734
[No Abstract] [Full Text] [Related]
17. Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature.
Wang L; Du F; Zhang HM; Wang HX
Braz J Med Biol Res; 2015 Jul; 48(7):583-7. PubMed ID: 26017341
[TBL] [Abstract][Full Text] [Related]
18. Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy.
Muraoka M; Okuma C; Kanamitsu K; Ishida H; Kanazawa Y; Washio K; Seki M; Kato M; Takita J; Sato Y; Ogawa S; Tsukahara H; Oda M; Shimada A
J Hum Genet; 2016 Jun; 61(6):523-6. PubMed ID: 26911351
[TBL] [Abstract][Full Text] [Related]
19. Rare Variant Quantitation Using Droplet Digital PCR.
Parkin B
Methods Mol Biol; 2019; 1881():239-251. PubMed ID: 30350210
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanism and progress in treatment of juvenile myelomonocytic leukemia (JMML)].
Koike K; Matsuda K
Rinsho Ketsueki; 2013 Jun; 54(6):538-44. PubMed ID: 23823092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
